Pulmonary Arterial Hypertension in Hispanics.

hispanic/latino health pulmonary hypertension pulmonary medicine

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
04 Oct 2019
Historique:
entrez: 23 11 2019
pubmed: 23 11 2019
medline: 23 11 2019
Statut: epublish

Résumé

Pulmonary hypertension (PH) is a medical condition characterized by elevated pressures in the pulmonary vessels. Pulmonary arterial hypertension (PAH), or pre-capillary PH, is a subgroup of the broader PH definition. PAH is rare compared to other groups of PH; its prevalence is about 15 cases per million in the adult population. Several disease processes may lead to PAH; however, the most common cause of PAH is idiopathic. Until recently, treatment for PAH was very limited and prognosis was dismal. Limitations in management remain present today but more treatment options are available for patients suffering from this condition.  Most of the information available regarding PAH comes from registries in the United States and Europe. Limited information about epidemiology, treatment options, and response to the treatment is available for other ethnic groups such as Hispanics. In the world of medicine, we have learned from other more common medical conditions that components, such as genetics, environment, and culture may affect how diseases manifest and how they respond to treatment. It is important to be aware of how different ethnic groups exposed to different environmental conditions respond to different treatment modalities. The aim of this paper is to review the limited data available regarding PAH in Hispanics. This paper will review the information regarding the etiology, diagnosis, and treatment modalities available in South American and Central American countries. This paper will also review the data available for Hispanics diagnosed with PAH living in the United States. The goal is to highlight the difference in how PAH manifests in Hispanics compared to other ethnic groups. We aim to emphasize the importance of the lack of data available for this group and how it may be affecting the way we are treating Hispanics with PAH.

Identifiants

pubmed: 31754569
doi: 10.7759/cureus.5834
pmc: PMC6827697
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

e5834

Informations de copyright

Copyright © 2019, Diaz et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Am J Respir Crit Care Med. 2009 Apr 1;179(7):615-21
pubmed: 19164700
BMC Pulm Med. 2018 Jun 26;18(1):106
pubmed: 29940945
J Appl Physiol (1985). 2014 Apr 1;116(7):875-84
pubmed: 24201705
Chest. 2012 Jan;141(1):20-26
pubmed: 21940766
Thorax. 1999 Dec;54(12):1107-18
pubmed: 10567632
Lancet. 2003 May 3;361(9368):1533-44
pubmed: 12737878
Chest. 2011 Jan;139(1):128-37
pubmed: 20558556
Ann Intern Med. 1991 Sep 1;115(5):343-9
pubmed: 1863023
Chest. 2007 Jun;131(6):1917-28
pubmed: 17565025
Chest. 2013 Mar;143(3):758-766
pubmed: 23580984
Chest. 2018 Feb;153(2):310-320
pubmed: 28887060
Chest. 2015 Feb;147(2):495-501
pubmed: 25317567
Am Heart J. 2006 Sep;152(3):521-6
pubmed: 16923424

Auteurs

Raiko Diaz (R)

Pulmonary Medicine, Aventura Hospital and Medical Center, Aventura, USA.

Gustavo Ferrer (G)

Pulmonary and Critial Care Medicine, Aventura Hospital and Medical Center, Aventura, USA.

Classifications MeSH